glutathione drip fda approved IV Therapy | Katy, TX FDA Advisory No. 2019-182 ||
Description
Supernatant from uninfected cells was used as a negative control and from cells lysed with 1% triton X-100 (final concentration) was a positive control

Statistical significance was assessed using two-tailed paired t-test
Urasawa, T., Koizumi, T., Kimura, K., Ohta, Y

Some advanced research protocols do explore concurrent use